HBIO (Harvard Bioscience, Inc.) Market Value to Book Value Ratio

This daily price chart for Harvard Bioscience (HBIO) reflects the price action of a molecular analysis systems manufacturer whose profits are based on the sale of proprietary consumables at a value of 5.13. The modernization of CNC machines allows workshops to process accumulated orders more rapidly. However, risks include a reduction in government science funding and pricing pressure from Eastern equipment suppliers.

HBIO - Harvard Bioscience Inc. Market-to-Book Ratio over the range 07/04/2022 - 10/27/2026

HBIO (Harvard Bioscience Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:

Price Chart Harvard Bioscience, Inc.|HBIO - Average Forecast Price

- market capitalization data:

Market Value Harvard Bioscience|HBIO - Real Price to Acquire Entire Company

- book capitalization data:

Book Value per Share Harvard Bioscience|HBIO - Total Stockholders' Equity|Market Capitalization to Book Value Ratio harvardbioscience.com|HBIO - Total Business Assets

- debt and liquidity data:

Total Debt to Capital Harvard Bioscience|HBIO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Harvard Bioscience|HBIO - Company Total Debt|Debts to Book Capitalization Harvard Bioscience

Initial company analysis:Harvard Bioscience, Inc. - HBIO

Manufactured products of Harvard Bioscience Inc.

This ratio compares the market value of the business with its net assets to determine the premium over capital. The metric measures the gap between the exchange valuation and the actual value of the assets, signaling whether the asset is overbought. The price action of the market-to-book ratio reflects the current margin of safety for investments. Transparent oversight by the experienced management of Harvard Bioscience (HBIO) minimizes the risk of inefficient resource allocation, ensuring the fundamental stability of the company's capitalization.

Direct competitors